Investors should adopt a slow Dollar Cost Averaging (DCA) strategy for Bitcoin (BTC), keeping cash reserves for a potential dip into the low $50,000s as the market consolidates over the next 3 to 4 months. Eli Lilly (LLY) remains a high-conviction "buy and hold" anchor, but investors should wait for pullbacks to the 10-day (~$1,115) or 20-day (~$1,050) moving averages for better entry points. Within the crypto space, prioritize Hyperliquid (HYPE) and Venice (VENICE) over major Layer-1s, as these assets offer real cash flows and are currently nearing technical reset levels. Avoid heavy positions in Ethereum (ETH) and Solana (SOL) for now, as both have broken major support and have not yet finished their bottoming process. For broader stock market exposure, look for buying opportunities in major indices toward the end of this week or early next week as the current technical correction matures.

Bitcoin (BTC)

The "king of the crypto world" is currently exhibiting signs of a bottoming pattern, though analysts caution that the absolute bottom may not be in yet. Historically, the 200-week simple moving average has acted as a "line in the sand" for bear market bottoms, and the price is currently testing these levels.

• Bullish Divergence: A bullish divergence is appearing on the RSI (Relative Strength Index). While prices hit lower lows recently, the momentum (RSI) hit a higher low, suggesting selling pressure is waning.
• Weekly Megatrend: The weekly trend recently flipped "red" (bearish). Historically, these trends do not flip back to green quickly, suggesting a period of sideways consolidation is likely.
• Time vs. Price: While the current price (low $60k range) is considered a "decent level" for long-term buyers, the timeframe for a full recovery is estimated at 3 to 4 months (potentially lasting until October).
• Risk Factors: A dip into the low $50,000s remains a realistic probability before a true reversal occurs.

Takeaways

• Patience is Key: Avoid "going all in" immediately. The market likely needs 3-4 months of sideways "chop" to allow moving averages to catch up to the price.
• DCA Strategy: If you wish to buy, start a slow Dollar Cost Averaging (DCA) schedule. Chipping away at these levels is reasonable for a 1-year horizon, but keep cash reserves for a potential leg down to the $50k range.

Eli Lilly (LLY)

A pharmaceutical giant that is increasingly being viewed as an AI play. The company is using its massive historical drug trial data to train private AI models, significantly speeding up R&D.

• Financial Strength: The company is "flush with cash" from its GLP-1 (weight loss) drugs, allowing it to fund data centers and NVIDIA GPU purchases without borrowing.
• Technical Status: Currently overextended and showing waning momentum (bearish divergence on the RSI).
• Market Cap: Over $1 trillion, but analysts see potential for a 2x to 3x return over the next few years as it matures into an AI-driven healthcare leader.

Takeaways

• Investment Anchor: Consider LLY as a "core portfolio anchor" due to its low volatility and high upside.
• Entry Points: Look for pullbacks to the 10-day moving average (~$1,115) or the 20-day moving average (~$1,050) for better entry points.
• Long-term View: This is a "buy and hold" asset rather than a swing trade.

Hyperliquid (HYPE) & Venice (VENICE)

These assets are highlighted as having narratives that exist outside of the general crypto "bubble," specifically tied to AI and TradFi cash flows.

• Hyperliquid: Recently saw a "healthy correction" after being overextended. It is noted for having a real cash flow profile and occasionally beating Ethereum in trading volume.
• Venice: A private AI inference platform. It is currently correcting toward its 10-week moving average, which is viewed as a technical reset rather than a fundamental failure.
• Relative Strength: Both are considered "top picks" because they provide actual value/yield to token holders, unlike many speculative altcoins.

Takeaways

• Preferred Alts: If forced to buy crypto right now, analysts prefer Venice or Hyperliquid over major Layer-1s like Solana or Ethereum.
• Wait for Exhaustion: Both are near the end of a "setup count" (DMARC 7), suggesting a few more days of downside might occur before they are fully exhausted and ready for a bounce.

Altcoin Sector (ETH, SOL, SUI, NEAR)

The general sentiment for major Altcoins is bearish to neutral in the short term.

• Ethereum (ETH) & Solana (SOL): Both have broken down through major support levels and are trading well below their 200-day moving average clouds.
• Near Protocol (NEAR): Shows better relative strength due to its AI narrative but is still at risk if the broader crypto market continues to bleed.
• Zcash (ZEC): Recently suffered a "critical flaw" discovery. While the price bounced 80% from the lows because the exploit wasn't actually used, it remains a high-risk "faith-based" play.

Takeaways

• Avoid Chasing: It is "way too soon" to jump heavily into ETH or SOL. They have not finished their bottoming process.
• Relative Strength: Only look at alts that are holding above their 200-day moving average cloud (e.g., Tron (TRX) or Near (NEAR)), but exercise extreme caution.

Macro & Stock Market Outlook

The broader market is undergoing a short-term technical correction.

• Indices: Major stock indices (S&P 500, Nasdaq) hit "DMARC 9" exhaustion signals on weekly charts, leading to a "mean reversion" (pullback).
• The Dollar (DXY): The US Dollar is at the top of its range. A breakout here would be bad for crypto, but a rejection would be bullish.
• Liquidity: Global liquidity has been stagnant since April, providing no "tailwind" for asset prices.

Takeaways

• Healthy Correction: The current stock market dip is viewed as a technical correction rather than a crash, as credit spreads remain stable.
• Timing: Look for potential buying opportunities in stocks toward the end of the week or early next week as the correction matures.